Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Glaucoma > AI-assisted glaucoma screening offers promise in glaucoma detection but requires further refinement
  • Glaucoma

AI-assisted glaucoma screening offers promise in glaucoma detection but requires further refinement

Kelsey Moroz

OpenAI’s GPT-4V demonstrates potential as a tool for glaucoma screening and detection through fundus image analysis, showing strong consistency in certain diagnostic features and moderate agreement with expert evaluations, according to a study. However, its performance varies across datasets and is slightly less accurate than human experts, highlighting room for improvement in its diagnostic capabilities.

Using 300 fundus images from 3 public datasets—ACRIMA, ORIGA, and RIM-One v3—the study analyzed GPT-4V’s ability to evaluate image quality, cup-to-disc ratio, rim thinning, and other glaucoma indicators. Each image underwent preprocessing to focus on the optic disc, and GPT-4V analyzed the images twice to assess consistency. Two expert graders independently reviewed the same images for comparison.

GPT-4V accurately analyzed all 300 images, though 35% required multiple prompts. Its overall accuracy in glaucoma detection was slightly lower than the experts, with scores ranging from 0.68 to 0.81 across datasets, compared to expert accuracies of 0.72 to 0.88. Agreement with experts varied by dataset, with Cohen kappa values between 0.08 and 0.72. However, GPT-4V showed high consistency in assessing image gradability (≥89%) and strong agreement in cup-to-disc ratio and rim thinning evaluations.

The study concluded that GPT-4V demonstrates potential as a tool for glaucoma screening, offering significant agreement with expert evaluations, though its performance varies depending on the dataset and specific diagnostic features.

Reference
Jalili J, Jiravarnsirikul A, Bowd C, et al. Glaucoma Detection and Feature Identification via GPT-4V Fundus Image Analysis. Ophthalmol Sci. 2024;5(2):100667. doi: 10.1016/j.xops.2024.100667. PMID: 39877464; PMCID: PMC11773068.

Share

Related Content

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

  • Glaucoma

GLP-1 therapies may offer potential benefits in glaucoma

  • Trending Topics

AI-based diagnostics show promise for early ocular disease detection

  • Trending Topics

Study explores retinal findings in pregnant women with COVID-19

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Glaucoma

iStent adoption rises as surgeons treat glaucoma earlier

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon